218,219 Targeting H 2 S biosynthesis The inhibition of H 2 S biosynthesis has been shown to sensitise cancer cells to chemotherapy, as it disturbs the mitochondrial equilibrium by impairing bioenergetics
A research piece in JAMA from January 2025, examining over 125,000 individuals who were overweight or obese, indicated that almost 47% of participants with type 2 diabetes and 65% without diabetes ceased using their prescribed GLP-1s within twelve months of initiation
Antihistamine properties may help reduce itching associated with eczema
Methylene Blue: The Mitochondrial Optimizer Methylene Blue has a long history of medical use, but more recent research has highlighted its role in brain energy metabolism
GLP-1 Examples A 2023 update 6 tells us there are currently seven GLP-1 receptor agonists, including: Exenatide Brand name: Byetta Dosage: twice-daily injection Exenatide extended-release Brand name: Bydureon Dosage: once-weekly injection Lixisenatide Brand name: Adlyxin Dosage: once-daily injection Liraglutide Brand names: Victoza and Saxenda Dosage: once-daily injection Dulaglutide Brand names: Trulicity Dosage: once-weekly injection Semaglutide Brand names: Ozempic and Wegovy Dosage: once-weekly injection Oral semaglutide Brand name: Rybelsus Dosage: once-daily injection We also can't overlook tirzepatide (branded as Mounjaro), which is the first agonist that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors